Display options
Share it on

Oncol Lett. 2017 Oct;14(4):4722-4728. doi: 10.3892/ol.2017.6800. Epub 2017 Aug 23.

Combined use of alcohol in conventional chemical-induced mouse liver cancer model improves the simulation of clinical characteristics of human hepatocellular carcinoma.

Oncology letters

Bo Xin, Ying Cui, Yanxia Wang, Lei Wang, Jipeng Yin, Licheng Zhang, Hailin Pang, Helong Zhang, Rui-An Wang

Affiliations

  1. Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China.
  2. Department of Oncology, No. 88 Hospital of People's Liberation Army, Tai'an, Shandong 271000, P.R. China.
  3. Department of Transfusion, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi 710038, P.R. China.
  4. Department of Pathology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
  5. State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.
  6. State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China.

PMID: 29085472 PMCID: PMC5649534 DOI: 10.3892/ol.2017.6800

Abstract

Liver cancer is the one of most common types of cancer and the 2nd cause of cancer-associated mortalities worldwide. Establishing appropriate animal models of liver cancer is essential for basic and translational studies. The present study evaluated the effects of the combined use of alcohol with a conventional chemical-induced mouse liver cancer model. The treatment of alcohol/diethylnitrosamine (DEN)/carbon tetrachloride (CCl

Keywords: alcohol; carcinogenesis; hepatic lesions; histology; murine

References

  1. Lancet. 2014 Sep 13;384(9947):980-1004 - PubMed
  2. Minerva Med. 2011 Oct;102(5):363-71 - PubMed
  3. Gastroenterology. 2015 Jan;148(1):30-6 - PubMed
  4. Gastroenterology. 2014 May;146(5):1249-55.e1 - PubMed
  5. N Engl J Med. 2003 Apr 24;348(17):1625-38 - PubMed
  6. J Hepatol. 2015 Sep;63(3):722-32 - PubMed
  7. Biomolecules. 2015 Aug 28;5(3):2023-34 - PubMed
  8. Int J Clin Exp Pathol. 2015 Jul 01;8(7):8655-62 - PubMed
  9. Nat Genet. 2002 Aug;31(4):339-46 - PubMed
  10. Anticancer Res. 2014 Dec;34(12):7029-37 - PubMed
  11. J Hepatol. 2016 Jan;64(1):203-14 - PubMed
  12. Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14 - PubMed
  13. J Hepatol. 2010 Jun;52(6):939-40 - PubMed
  14. Cancer Cell. 2012 Apr 17;21(4):504-16 - PubMed
  15. J Gastroenterol Hepatol. 2013 Sep;28(9):1545-54 - PubMed
  16. Mol Oncol. 2013 Apr;7(2):206-23 - PubMed
  17. Science. 1966 Apr 1;152(3718):83-5 - PubMed
  18. Carcinogenesis. 1986 Feb;7(2):215-20 - PubMed
  19. Nat Rev Cancer. 2006 Sep;6(9):674-87 - PubMed
  20. Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1548-53 - PubMed
  21. Hepatology. 2001 Jul;34(1):101-8 - PubMed
  22. Gastroenterol Res Pract. 2010;2010:null - PubMed
  23. Dig Dis. 2012;30 Suppl 1:55-60 - PubMed
  24. J Gastroenterol Hepatol. 2000 Mar;15 Suppl:D20-5 - PubMed
  25. J Hepatol. 2010 Dec;53(6):1078-84 - PubMed
  26. Int J Cancer. 2008 Jun 15;122(12):2682-8 - PubMed
  27. J Hepatol. 2013 Nov;59(5):1007-13 - PubMed
  28. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29 - PubMed
  29. Cell. 2010 Jan 22;140(2):197-208 - PubMed
  30. Free Radic Biol Med. 2001 Dec 15;31(12):1544-9 - PubMed
  31. Hepat Med. 2012 May 08;4:19-37 - PubMed
  32. Hepatology. 2011 Dec;54(6):2185-97 - PubMed

Publication Types